Role of cytoreductive surgery in recurrent ovarian cancer.
Standard
Role of cytoreductive surgery in recurrent ovarian cancer. / Harter, Philipp; Hilpert, Felix; Mahner, Sven; Kommoss, Stefan; Heitz, Florian; Andreas, Du Bois.
In: EXPERT REV ANTICANC, Vol. 9, No. 7, 7, 2009, p. 917-922.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Role of cytoreductive surgery in recurrent ovarian cancer.
AU - Harter, Philipp
AU - Hilpert, Felix
AU - Mahner, Sven
AU - Kommoss, Stefan
AU - Heitz, Florian
AU - Andreas, Du Bois
PY - 2009
Y1 - 2009
N2 - Cytoreductive surgery is well established in patients with primary ovarian cancer. The benefit of surgery in patients with recurrent ovarian cancer remains a controversial matter. There is a large heterogeneity in surgical results published in the literature, possibly caused by infrastructure, surgeons' philosophy and belief in adding various surgical skills. This might also be a result of different preoperative selection procedures. Further questions to be addressed are the definition of surgical end points and whether there are predictive factors for a successful surgery. The surgical end point in recurrent ovarian cancer should be complete resection. Predictive factors could help identify patients in whom complete resection is possible.
AB - Cytoreductive surgery is well established in patients with primary ovarian cancer. The benefit of surgery in patients with recurrent ovarian cancer remains a controversial matter. There is a large heterogeneity in surgical results published in the literature, possibly caused by infrastructure, surgeons' philosophy and belief in adding various surgical skills. This might also be a result of different preoperative selection procedures. Further questions to be addressed are the definition of surgical end points and whether there are predictive factors for a successful surgery. The surgical end point in recurrent ovarian cancer should be complete resection. Predictive factors could help identify patients in whom complete resection is possible.
M3 - SCORING: Zeitschriftenaufsatz
VL - 9
SP - 917
EP - 922
JO - EXPERT REV ANTICANC
JF - EXPERT REV ANTICANC
SN - 1473-7140
IS - 7
M1 - 7
ER -
